Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Hengan International Reassigns Veteran Executive Xu Wenmo to Non-Executive Board Role

Tipranks - Wed Apr 15, 11:18PM CDT

Claim 30% Off TipRanks

Hengan International Group Co ( (HK:1044) ) has shared an update.

Hengan International Group has proposed the re-designation of Xu Wenmo from executive director to non-executive director, effective after his expected re-election at the 18 May 2026 annual general meeting. Xu, currently vice president overseeing legal and risk management as well as internal and external audit, has been with the group since 1985 and brings more than 37 years of consumer products experience.

Following his re-election, the company plans to enter a new appointment letter with Xu, providing a HK$60,000 annual director’s fee and allowing additional remuneration for his other roles within the group. The move formalizes his ongoing strategic involvement while reflecting a shift away from day-to-day executive duties, and confirms his significant shareholding interest, including stakes held via a trust structure, aligning his interests with those of other shareholders.

The most recent analyst rating on (HK:1044) stock is a Hold with a HK$26.00 price target. To see the full list of analyst forecasts on Hengan International Group Co stock, see the HK:1044 Stock Forecast page.

More about Hengan International Group Co

Hengan International Group Company Limited is a Cayman Islands–incorporated company listed in Hong Kong that operates in the consumer products sector. The group focuses on the manufacture and sale of household and personal care items, leveraging more than three decades of experience in management, marketing and sales of consumer goods in mainland China and broader Asian markets.

Average Trading Volume: 2,889,370

Technical Sentiment Signal: Hold

Current Market Cap: HK$32.71B

For detailed information about 1044 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.